CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma

Multiple Myeloma (MM) is a hematological cancer characterized by proliferation of malignant plasma cells in the bone marrow (BM). MM represents the second most frequent hematological malignancy, accounting 1% of all cancer and 13% of hematological tumors, with ~9,000 new cases per year. Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Morandi, Fabio, Horenstein, Alberto L., Costa, Federica, Giuliani, Nicola, Pistoia, Vito, Malavasi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279879/
https://www.ncbi.nlm.nih.gov/pubmed/30546360
http://dx.doi.org/10.3389/fimmu.2018.02722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279879/
https://www.ncbi.nlm.nih.gov/pubmed/30546360
http://dx.doi.org/10.3389/fimmu.2018.02722

Ejemplares similares